Patents Assigned to Paradigm Biomedical, Inc.
  • Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration
    Patent number: 7129218
    Abstract: Various methods are provided, including re-epithelization and wound healing with reduced fibrosis, particularly for the re-epithelization of mucous membrane tissues, most particularly for the treatment and prevention of gum disease and for periodontal regeneration, each of which uses administration of a composition containing one or more rhamnolipids as an active ingredient. The figure provides a graphical representation of the effects of topical BAC-3 on the rate of burn wound closure.
    Type: Grant
    Filed: August 7, 2000
    Date of Patent: October 31, 2006
    Assignee: Paradigm Biomedical, Inc.
    Inventors: Tamara Stipcevic, Tihana Piljac, Jasenka Piljac, Tatjana Dujmic, Goran Piljac